Literature DB >> 32463076

Asymptomatic Transmission During the Coronavirus Disease 2019 Pandemic and Implications for Public Health Strategies.

Hanalise V Huff1, Avantika Singh1.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly in a few months despite global public health strategies to curb transmission by testing symptomatic patients and social distancing. This review summarizes evidence that highlights transmission by asymptomatic and presymptomatic individuals. Viral load of asymptomatic and symptomatic cases is comparable. Viral shedding is highest before symptom onset, suggesting high transmissibility before symptoms. Within universally tested subgroups, high percentages of SARS-CoV-2 infected asymptomatic individuals were found. Asymptomatic transmission was reported in several clusters, including a Wuhan study showing an alarming rate of intrahospital transmission. Several countries reported higher prevalence among healthcare workers than general population raising concern that healthcare workers could act as silent vectors. Therefore, current strategies that rely solely on "symptom onset" for infection identification need urgent reassessment. Extensive universal testing irrespective of symptoms may be considered, with priority placed on groups with high frequency exposure to positive patients.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; asymptomatic; public health; transmission

Year:  2020        PMID: 32463076      PMCID: PMC7314132          DOI: 10.1093/cid/ciaa654

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  74 in total

1.  Outbreak of SARS-CoV-2 infection at a large refugee shelter in Toronto, April 2020: a clinical and epidemiologic descriptive analysis.

Authors:  Vanessa Redditt; Vanessa Wright; Meb Rashid; Roy Male; Isaac Bogoch
Journal:  CMAJ Open       Date:  2020-12-08

2.  Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans.

Authors:  Julia Koch-Heier; Annika Schönsiegel; Lara Maria Waidele; Julian Volk; Yvonne Füll; Christian Wallasch; Sebastian Canisius; Michael Burnet; Oliver Planz
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

Review 3.  Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic.

Authors:  Yutong Wang; Ke Zheng; Wenjing Gao; Jun Lv; Canqing Yu; Lan Wang; Zijun Wang; Bo Wang; Chunxiao Liao; Liming Li
Journal:  Med Rev (Berl)       Date:  2022-02-24

Review 4.  Opportunities for biomaterials to address the challenges of COVID-19.

Authors:  Daniel Chakhalian; Robert B Shultz; Catherine E Miles; Joachim Kohn
Journal:  J Biomed Mater Res A       Date:  2020-08-04       Impact factor: 4.854

Review 5.  Occupational Respiratory Infections.

Authors:  Marie A de Perio; Miwako Kobayashi; Jonathan M Wortham
Journal:  Clin Chest Med       Date:  2020-12       Impact factor: 2.878

6.  Dealing with COVID-19 Epidemic in Italy: Responses from Regional Organizational Models during the First Phase of the Epidemic.

Authors:  Maria Lucia Specchia; Andrea Di Pilla; Martina Sapienza; Maria Teresa Riccardi; Americo Cicchetti; Gianfranco Damiani; Instant Report Group
Journal:  Int J Environ Res Public Health       Date:  2021-05-09       Impact factor: 3.390

7.  Why Do People (Not) Engage in Social Distancing? Proximate and Ultimate Analyses of Norm-Following During the COVID-19 Pandemic.

Authors:  James O Norton; Kortnee C Evans; Ayten Yesim Semchenko; Laith Al-Shawaf; David M G Lewis
Journal:  Front Psychol       Date:  2021-06-23

8.  Unrealistic Optimism and Risk for COVID-19 Disease.

Authors:  Jeffrey Gassen; Tomasz J Nowak; Alexandria D Henderson; Sally P Weaver; Erich J Baker; Michael P Muehlenbein
Journal:  Front Psychol       Date:  2021-06-04

9.  Seroprevalence of human coronaviruses among patients visiting hospital-based sentinel sites in Uganda.

Authors:  Elijah Nicholas Mulabbi; Robert Tweyongyere; Fred Wabwire-Mangen; Edison Mworozi; Jeff Koehlerb; Hannah Kibuuka; Monica Millard; Bernard Erima; Titus Tugume; Ukuli Qouilazoni Aquino; Denis K Byarugaba
Journal:  BMC Infect Dis       Date:  2021-06-16       Impact factor: 3.090

10.  SARS-CoV-2 antibodies in adults in Madrid, Spain.

Authors:  Vicente Soriano; Rosa Meiriño; Octavio Corral; María Pilar Guallar
Journal:  Clin Infect Dis       Date:  2020-06-16       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.